Cargando…
Antibiotics for the treatment of dysentery in children
Background Ciprofloxacin, ceftriaxone and pivmecillinam are the antibiotics currently recommended by the World Health Organization (WHO) for the treatment of dysentery in children; yet there have been no reviews of the clinical effectiveness of these antibiotics in recent years. Methods We reviewed...
Autores principales: | , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2845863/ https://www.ncbi.nlm.nih.gov/pubmed/20348130 http://dx.doi.org/10.1093/ije/dyq024 |
_version_ | 1782179448074797056 |
---|---|
author | Traa, Beatrix S Walker, Christa L Fischer Munos, Melinda Black, Robert E |
author_facet | Traa, Beatrix S Walker, Christa L Fischer Munos, Melinda Black, Robert E |
author_sort | Traa, Beatrix S |
collection | PubMed |
description | Background Ciprofloxacin, ceftriaxone and pivmecillinam are the antibiotics currently recommended by the World Health Organization (WHO) for the treatment of dysentery in children; yet there have been no reviews of the clinical effectiveness of these antibiotics in recent years. Methods We reviewed all literature reporting the effect of ciprofloxacin, ceftriaxone and pivmecillinam for the treatment of dysentery in children in the developing countries. We used a standardized abstraction and grading format and performed meta-analyses to determine the effect of treatment with these antibiotics on rates of treatment failure, bacteriological failure and bacteriological relapse. The CHERG Standard Rules were applied to determine the final effect of treatment with these antibiotics on diarrhoea mortality. Results Eight papers were selected for abstraction. Treatment with ciprofloxacin, ceftriaxone or pivmecillinam resulted in a cure rate of >99% while assessing clinical failure, bacteriological failure and bacteriological relapse. Conclusions The antibiotics recommended by the WHO—ciprofloxacin, ceftriaxone and pivmecillinam—are effective in reducing the clinical and bacteriological signs and symptoms of dysentery and thus can be expected to decrease diarrhoea mortality attributable to dysentery. |
format | Text |
id | pubmed-2845863 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2010 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-28458632010-03-29 Antibiotics for the treatment of dysentery in children Traa, Beatrix S Walker, Christa L Fischer Munos, Melinda Black, Robert E Int J Epidemiol Articles Background Ciprofloxacin, ceftriaxone and pivmecillinam are the antibiotics currently recommended by the World Health Organization (WHO) for the treatment of dysentery in children; yet there have been no reviews of the clinical effectiveness of these antibiotics in recent years. Methods We reviewed all literature reporting the effect of ciprofloxacin, ceftriaxone and pivmecillinam for the treatment of dysentery in children in the developing countries. We used a standardized abstraction and grading format and performed meta-analyses to determine the effect of treatment with these antibiotics on rates of treatment failure, bacteriological failure and bacteriological relapse. The CHERG Standard Rules were applied to determine the final effect of treatment with these antibiotics on diarrhoea mortality. Results Eight papers were selected for abstraction. Treatment with ciprofloxacin, ceftriaxone or pivmecillinam resulted in a cure rate of >99% while assessing clinical failure, bacteriological failure and bacteriological relapse. Conclusions The antibiotics recommended by the WHO—ciprofloxacin, ceftriaxone and pivmecillinam—are effective in reducing the clinical and bacteriological signs and symptoms of dysentery and thus can be expected to decrease diarrhoea mortality attributable to dysentery. Oxford University Press 2010-04 2010-03-23 /pmc/articles/PMC2845863/ /pubmed/20348130 http://dx.doi.org/10.1093/ije/dyq024 Text en Published by Oxford University Press on behalf of the International Epidemiological Association. © The Author 2010; all rights reserved. http://creativecommons.org/licenses/by-nc/2.5/uk/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Articles Traa, Beatrix S Walker, Christa L Fischer Munos, Melinda Black, Robert E Antibiotics for the treatment of dysentery in children |
title | Antibiotics for the treatment of dysentery in children |
title_full | Antibiotics for the treatment of dysentery in children |
title_fullStr | Antibiotics for the treatment of dysentery in children |
title_full_unstemmed | Antibiotics for the treatment of dysentery in children |
title_short | Antibiotics for the treatment of dysentery in children |
title_sort | antibiotics for the treatment of dysentery in children |
topic | Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2845863/ https://www.ncbi.nlm.nih.gov/pubmed/20348130 http://dx.doi.org/10.1093/ije/dyq024 |
work_keys_str_mv | AT traabeatrixs antibioticsforthetreatmentofdysenteryinchildren AT walkerchristalfischer antibioticsforthetreatmentofdysenteryinchildren AT munosmelinda antibioticsforthetreatmentofdysenteryinchildren AT blackroberte antibioticsforthetreatmentofdysenteryinchildren |